|
MADISON - A $23.6 million expansion of the Waisman Center has the potential
to advance interdisciplinary scientific research at the University of Wisconsin-Madison
to the forefront of international efforts to unravel the mysteries in several
dynamic and emerging scientific fields.
World renowned for its research on human development and developmental
disabilities, the Center will become a focal point for innovative work in
the areas of human gene therapy and greater understanding of the human brain.
In addition, the Center's model early intervention and inclusive early Outreach
programs will be expanded.
Funded entirely by private gifts and grants, the seven-story, 68,486
gross square foot addition to the Center will include:
* State-of-the-art research laboratories and support facilities for human
gene therapy research,
* A biopharmaceutical production facility that will provide campus investigators
with materials for human clinical trials,
* New facilities for functional imaging of the human brain,
* Increased space and new facilities for the early intervention programs,
* A 100-seat conference center with advanced audio/visual systems and
interactive technology,
* Increased space for the Waisman Early Childhood Program, and
* A central reception and information area.
The Human Gene Therapy Center is designed and equipped to put the UW-Madison
at the cutting edge of a concerted world-wide push among scientists and
researchers to translate and apply the information gained in recent research
in molecular biology.
That research involves the elucidation of the genetic mechanisms involved
in human development and health and in dramatic new opportunities to transfer
healthy genes into human tissue to cure or prevent what have been "incurable"
diseases. At the Waisman Center, that research focuses on profound or fatal
diseases such as Duchenne muscular dystrophy, neurodegenerative diseases
such as leukodystrophies and Parkinson's disease, and metabolic diseases
such as phenylketonuria in which children are missing a key enzyme critical
to good health.
In addition, with nearly 100 other related research projects currently
under way throughout the UW campus, the Gene Therapy Center will support
that research and accelerate discoveries so they may be applied to a wide
range of human diseases through clinical intervention.
Another element of the expansion project will further enhance the university's
efforts to develop and utilize brain imaging technologies - positron emission
tomography and functional magnetic resonance imaging - to study child development.
By allowing researchers to peer inside the working brain of a subject
engaged in well defined tasks, the technology will advance the understanding
of cognitive development and foster the creation of new knowledge about
emotional and mental health, according to Waisman scientists. Acquisition
of that knowledge will further the effectiveness of neuroscience research
in fields such as psychology, psychiatry, medical physics and radiology.
In addition to the new scientific facilities, a major renovation of the
existing single-story west wing will allow for the expansion of the Waisman
Early Childhood Program and provide adjacent areas for collaborative research
programs. This will permit the WECP to serve more children and families,
expand its research and training capabilities, and work more effectively
with other UW units that depend on the program for research and training
support.
The addition will be located on the northeast corner of the existing
tower to take advantage of lake views, facilitate a potential future skywalk
connection over Highland Avenue to the Clinical Sciences Center, and minimize
impacts to the neighboring Shorewood residential area to the southwest of
the existing facilities. The addition creates a landscape plaza on the south
to provide a pedestrian friendly environment with seat walls, tree plantings
and planting areas. The buff-toned face brick, precast panels, trim elements
and large expanses of glass to the north complement existing forms and materials,
while framing the views of the lake and campus vistas.
The Wisconsin Alumni Research Foundation, and gifts from private foundations,
and friends and alumni through the University of Wisconsin Foundation, have
provided the majority of funds for the project.
The lead donor is James F. Kress, DePere, Wis., chair and chief executive
officer of Green Bay Packaging, Inc., Green Bay, Wis. A 1951 UW graduate
in business, Kress made the gift on behalf of himself and his family through
the George F. Kress Foundation, Inc., founded by his late father, a 1925
graduate in finance, investment and banking. Other lead donors include William
('42 BS MechEngr) and Betty Jo Heckrodt, Menasha, Wis.; and the Oscar Rennebohm
Foundation, Inc., Madison, Wis.
Other individual donors are Sigrid and Gordon P. Connor ('59 BS MechEngr),
Laona, Wis.; Harriet Barg Gottlieb ('67 BA Eng), Pleasant Valley, Iowa;
John Marten Kelly ('71 BA, Econ), Oshkosh, Wis.; Oscar G. and Rosalie Mayer,
Rancho Mirage, Calif.; Daniel H. Neviaser, Madison, Wis.; Kathleen Daubert
Smith ('56 BS L&S) Tucson, Ariz.; Charlene Seabury-Houser ('44 BA L&S),
Wilmette, Ill.; Walter John J. Vollrath Jr. ('39 BA Econ) and June L. Vollrath,
Sheboygan, Wis.; and Kenneth R. Welton ('56 BS CivEngr & UrbLandEcon),
Middleton, Wis., and Naples, Fla.
Also contributing are the Aid Association for Lutherans, Appleton, Wis.;
the Terry Family Foundation, Madison, Wis.; the W.M. Keck Foundation, Los
Angeles; the Morrison Roberts Foundation, Hastings, Neb.; the Wausau Nationwide
Insurance Foundation, Columbus, Ohio; the Seabury Foundation, Chicago; and
the Marshall and Ilsley Foundation, Inc., and the Northwestern Mutual Life
Foundation, both of Milwaukee, Wis.
Architects and engineers for the expansion include Bowen, Williamson
and Zimmerman, Madison; Flad and Associates, Madison; and Arrowstreet, Inc.,
Somerville, Massachusetts. The general construction contractor will be JH
Findorff & Son, Inc., also of Madison.
***
Writer: Fred Milverstedt, UW Foundation, (608) 263-5496
|